A Study to Assess the Efficacy of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) on Exercise-induced Bronchoconstriction in Adults and Adolescents With Asthma
Condition:   Exercise Induced Bronchospasm Interventions:   Combination Product: Budesonide/albuterol sulfate metered-dose inhaler 160/180 μg;   Combination Product: Placebo metered-dose inhaler Sponsor:   Bond Avillion 2 Development LP Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 21, 2020 Category: Research Source Type: clinical trials

Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Injection by Intramuscular Injection and ProAir by Oral Inhalation in Healthy Individuals
Conditions:   Pharmacokinetics;   Epinephrine;   Albuterol;   Asthma;   Anaphylaxis Interventions:   Combination Product: Epinephrine (0.125 mg/inhalation);   Combination Product: Epinephrine Injection Auto-Injector (0.3mg/0.3mL);   Combination Product: Albuterol Sulfate (0.09 mg/inhalation) Sponsor:   Amphastar Pharmaceuticals, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 23, 2019 Category: Research Source Type: clinical trials

Mechanisms for Dyspnea on Exertion in Children With Obesity and Asthma
Conditions:   Asthma in Children;   Dyspnea; Asthmatic;   Obesity, Childhood Interventions:   Drug: Albuterol;   Other: Control Sponsor:   University of Nevada, Las Vegas Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2019 Category: Research Source Type: clinical trials

A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
Condition:   Asthma Interventions:   Drug: Albuterol eMDPI DS;   Drug: albuterol Sponsor:   Teva Branded Pharmaceutical Products, R&D  Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

Albuterol and Immune Cell Composition
Condition:   Immune Cell Composition Intervention:   Drug: Administration of albuterol Sponsor:   University of Arizona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
Condition:   Asthma Interventions:   Drug: Albuterol eMDPI DS;   Drug: albuterol Sponsor:   Teva Branded Pharmaceutical Products, R&D  Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

Albuterol and Immune Cell Composition
Condition:   Immune Cell Composition Intervention:   Drug: Administration of albuterol Sponsor:   University of Arizona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
Condition:   Asthma Interventions:   Drug: Albuterol eMDPI DS;   Drug: albuterol Sponsor:   Teva Branded Pharmaceutical Products, R&D  Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

Albuterol and Immune Cell Composition
Condition:   Immune Cell Composition Intervention:   Drug: Administration of albuterol Sponsor:   University of Arizona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
Condition:   Asthma Interventions:   Drug: Albuterol eMDPI DS;   Drug: albuterol Sponsor:   Teva Branded Pharmaceutical Products, R&D  Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

Albuterol and Immune Cell Composition
Condition:   Immune Cell Composition Intervention:   Drug: Administration of albuterol Sponsor:   University of Arizona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
Condition:   Asthma Interventions:   Drug: Albuterol eMDPI DS;   Drug: albuterol Sponsor:   Teva Branded Pharmaceutical Products, R&D  Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

Albuterol and Immune Cell Composition
Condition:   Immune Cell Composition Intervention:   Drug: Administration of albuterol Sponsor:   University of Arizona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
Condition:   Asthma Interventions:   Drug: Albuterol eMDPI DS;   Drug: albuterol Sponsor:   Teva Branded Pharmaceutical Products, R&D  Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

Albuterol and Immune Cell Composition
Condition:   Immune Cell Composition Intervention:   Drug: Administration of albuterol Sponsor:   University of Arizona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
Condition:   Asthma Interventions:   Drug: Albuterol eMDPI DS;   Drug: albuterol Sponsor:   Teva Branded Pharmaceutical Products, R&D  Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

Albuterol and Immune Cell Composition
Condition:   Immune Cell Composition Intervention:   Drug: Administration of albuterol Sponsor:   University of Arizona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
Condition:   Asthma Interventions:   Drug: Albuterol eMDPI DS;   Drug: albuterol Sponsor:   Teva Branded Pharmaceutical Products, R&D  Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials